Smith & Nephew plc

ISIN GB0009223206

 | 

WKN 502816

Market cap (in EUR)
11,245.11 m
Country
United Kingdom
Sector
Healthcare
Dividend yield
2.68%
 

Overview

Description

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT. The Advanced Wound Management segment includes advanced wound care, advanced wound bioactives, and advanced wound devices businesses. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.
Show more Show less
Healthcare Healthcare Equipment General Medical Devices United Kingdom

Financials

Key metrics

Market capitalisation, EUR 11,245.11 m
EPS, EUR -
P/B ratio 2.25
P/E ratio 29.26
Dividend yield 2.68%

Income statement (2024)

Revenue, EUR 5,372.18 m
Net income, EUR 380.95 m
Profit margin 7.09%

What ETF is Smith & Nephew plc in?

There are 230 ETFs which contain Smith & Nephew plc. All of these ETFs are listed in the table below. The ETF with the largest weighting of Smith & Nephew plc is the Amundi MSCI UK IMI SRI Climate Paris Aligned UCITS ETF - GBP (C).
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.